Home » Topics » BioWorld Science

BioWorld Science
RSS

monARC Bionetworks begins strategic integration with Roivant drug development platform

May 7, 2018

Lilly initiates phase III study of mirikizumab in moderate to severe plaque psoriasis

May 7, 2018

FDA grants priority review to Tecentriq sBLA for first-line treatment of metastatic NSCLC

May 7, 2018

Evolve doses first pediatric patient in phase III trial of PlasmaCap IG

May 7, 2018

Sage Therapeutics identifies GluN2A and/or GluN2B NAMs

May 7, 2018

Isofol receives FDA feedback on SPA for pivotal study of arfolitixorin in colorectal cancer

May 7, 2018

FDA approves Tafinlar with Mekinist for BRAF-positive anaplastic thyroid cancer

May 7, 2018

Merck & Co. patents novel LXR-beta agonists

May 7, 2018

Cancer therapy driven by dopamine D2 receptor antagonism shows promise

May 7, 2018

Novel oral antibiotic DDS-01 presented for treating multidrug-resistant gonorrhoea infections

May 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...